DrugDoses vs myAir™ by Resmed

DrugDoses

Oliver Karam
App Store
$700/mo
~$8.4K/yr · 2K installs
VS

myAir™ by Resmed

Resmed
Google Play
$0/mo
~$0/yr · 4.2M installs
Revenue winner DrugDoses wins +70000% vs other
Installs winner myAir™ by Resmed wins +240200% vs other
MAU winner myAir™ by Resmed wins +117234% vs other
Rating winner DrugDoses wins +7% vs other

Why DrugDoses is winning

Top 2 reasons - backed by the public App Store / Play Store numbers.

  1. DrugDoses earns roughly 700× more per month than myAir™ by Resmed - $700 vs $0.
  2. Better app store reviews. DrugDoses sits at 4.60★ vs 4.28★ - store algorithms reward higher-rated apps with more impressions.

Find more apps with this revenue gap · Full DrugDoses report

Side-by-side metrics

Bars scale to whichever app is bigger on that row. Green = winner.

DrugDoses
vs
myAir™ by Resmed
Monthly revenue (est.)?
$700
$0
Annual revenue (est.)
$8.4K
$0
Lifetime installs (est.)
2K
4.2M
Monthly active users (est.)?
448
526K
App Store rating
4.60★
4.28★
Total ratings
35
36K
US grossing rank
-
=
-
Cheapest monthly sub
No sub
=
No sub
IAP tiers detected
0 tiers
=
0 tiers

DrugDoses

Oliver Karam
App Store
Category
Medical
Price
USD14.99
Released
Jul 16, 2009
Last updated
Jun 21, 2025
File size
21.0 MB
Content rating
17+
Version
6.7.2
Languages
English
View full DrugDoses report →

myAir™ by Resmed

Resmed
Google Play
Category
Medical
Price
Free
Released
Apr 17, 2018
Last updated
Apr 10, 2026
File size
-
Content rating
Everyone
Version
VARY
Languages
-
View full myAir™ by Resmed report →

DrugDoses trajectory

JunJulAugSepOctNovDecJanFebMarAprMay

myAir™ by Resmed trajectory

JunJulAugSepOctNovDecJanFebMarAprMay

FAQ

Which makes more money, DrugDoses or myAir™ by Resmed? v
DrugDoses earns about $700 per month, while myAir™ by Resmed earns about $0. That is a ∞× revenue gap (~$700 more per month for DrugDoses). Annual revenue: DrugDoses ≈ $8.4K/year, myAir™ by Resmed ≈ $0/year. Estimates are derived from public App Store / Google Play signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.
Which has more downloads, DrugDoses or myAir™ by Resmed? v
myAir™ by Resmed leads with about 4.2M estimated downloads vs 2K for DrugDoses - a 2403.0× gap. DrugDoses's App Store downloads are estimated from 35 ratings × the standard 1:75 ratio. myAir™ by Resmed reports 1,000,000+ installs on Google Play.
Are DrugDoses and myAir™ by Resmed in the same App Store category on each store and competing for the same money? v
Yes - both apps sit in the Medical category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.
Do DrugDoses and myAir™ by Resmed have in-app purchases? v
DrugDoses does not appear to offer in-app purchases on its public listing. myAir™ by Resmed does not appear to offer in-app purchases. Monetization model: DrugDoses runs "Paid app ($14.99)", myAir™ by Resmed runs "No App Store revenue (monetizes off-store)".
Which has better ratings, DrugDoses or myAir™ by Resmed? v
DrugDoses edges ahead with ★ 4.6 vs ★ 4.3 (gap of 0.3 stars). Rating volume: DrugDoses 35 ratings, myAir™ by Resmed 11K ratings. Higher rating volume = stronger ASO signal even when star averages are close.
How accurate are these DrugDoses vs myAir™ by Resmed revenue estimates? v
Directional - typically within 2-3× of actual money earned for popular apps. The $700 for DrugDoses and $0 for myAir™ by Resmed are derived from App Store grossing rank / Google Play install ranges, scraped IAP tiers, ratings volume and category benchmarks (Medical) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.
How do I compare DrugDoses or myAir™ by Resmed to a different App Store app? v
Use the search box at the bottom of this page or paste any two App Store or Google Play links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.